NEW beclometasone / formoterol / glycopyrronium
PBS LISTING
THINK
TRIP
E
*
THINK
TRIMBOW1
NEW beclometasone / formoterol / glycopyrronium
PBS LISTING
FOR SEVERE ASTHMA( 100 / 6 / 10) 2
* Trimbow is the only triple therapy PBS listed for severe asthma in two strengths and COPD( 100 / 6 / 10) 2
Trimbow 100 / 6 / 10 & 200 / 6 / 10 are indicated for maintenance treatment; in adults with asthma not adequately controlled with a maintenance combination of medium dose or high dose ICS / LABA respectively, and who experienced ≥1 exacerbation( s) in the previous year. Trimbow 100 / 6 / 10 is indicated in adults with moderate to severe COPD who are not adequately treated by ICS / LABA or LABA / LAMA. 1
New PBS listing for severe asthma- Trimbow 100 / 6 / 10( medium ICS strength) 2
PBS listed for severe asthma- Trimbow 200 / 6 / 10( high ICS strength) 2 PBS listed for COPD- Trimbow 100 / 6 / 10( medium ICS strength) 2
PBS Information: Trimbow Authority required( STREAMLINED). Severe Asthma. Chronic Obstructive Pulmonary Disease( 100 / 6 / 10 mcg presentation only). Criteria Apply. Refer to PBS for full information.
COPD: chronic obstructive pulmonary disease; ICS: inhaled corticosteroid; LABA: long-acting beta 2 agonist; LAMA: long-acting muscarinic antagonist; PBS: Pharmaceutical Benefits Scheme. References: 1. Approved Trimbow Product Information. 2. Pharmaceutical Benefits Scheme. www. pbs. gov. au. Chiesi Australia Pty Ltd, Hawthorn East, VIC. 3123, Australia. Email: medinfo. au @ chiesi. com; Website: www. chiesi. com. au. Copyright © Chiesi 2025. All rights reserved. January 2025. AU-RES-2500017 CHIE00211B.